Does Medicaid Cover GLP-1 Medications?
Medicaid coverage for GLP-1 medications depends on what you are being treated for. States do not get to opt out of covering a GLP-1 approved for type 2 diabetes, for lowering heart attack and stroke risk, or for moderate to severe sleep apnea. Weight loss is the part each state decides for itself, and 13 states covered it under fee-for-service as of January 2026. Prior-approval requirements depend on the state, plan, medicine and indication.
Reviewed by GlobalGLP1 Editorial Team • Updated August 2026 • Sources: publicly available coverage data
Does Medicaid cover GLP-1s for weight loss?
It depends which state you are in, and it has been changing.
Weight loss is the one part of GLP-1 coverage each state decides for itself. These are the states where we can point to a sourced decision:
- California. California ended Medi-Cal coverage of GLP-1s for weight loss for members age 21 and older. (DHCS Medi-Cal Rx bulletin, November 14, 2025)
- Massachusetts. Since July 3, 2026, MassHealth no longer covers Wegovy, Zepbound, Saxenda or its other listed weight-loss medicines prescribed only for weight loss, except when medically necessary for members under 21. (MassHealth Pharmacy Facts #276, May 13, 2026)
- Michigan. Michigan tightened who qualifies for weight loss coverage.
- Missouri. Missouri added Medicaid coverage of GLP-1s for weight loss.
- New Hampshire. New Hampshire ended Medicaid coverage of GLP-1s for weight loss.
- North Carolina. North Carolina dropped weight loss coverage, then brought it back.
- Pennsylvania. Pennsylvania ended Medicaid coverage of GLP-1s for weight loss.
- Rhode Island. Since October 1, 2026, Rhode Island Medicaid no longer covers Foundayo, Saxenda, Wegovy or Zepbound prescribed solely for weight loss, except when medically necessary for members under 21. (Rhode Island EOHHS provider memo, August 5, 2026)
- South Carolina. South Carolina ended Medicaid coverage of GLP-1s for weight loss.
- Tennessee. Tennessee added Medicaid coverage of GLP-1s for weight loss.
- Utah. Utah added Medicaid coverage of GLP-1s for weight loss.
- Virginia. Virginia tightened who qualifies for weight loss coverage.
For the rest we do not hold a confirmed decision, and we would rather say so than guess. Open your state below to see what we have.
Across the country, 13 state Medicaid programs covered GLP-1s for weight loss under fee-for-service as of January 2026. That count covers fee-for-service Medicaid. Most people are in a Medicaid managed care plan instead, and those plans can make their own decisions, so your own plan is the thing to check.
Since then, MassHealth stopped covering Wegovy, Zepbound, Saxenda and other listed weight-loss medicines prescribed only for weight loss on July 3, 2026, and since October 1, 2026, Rhode Island Medicaid no longer covers Foundayo, Saxenda, Wegovy or Zepbound prescribed solely for weight loss. Both states still review requests for members under 21 for medical necessity.
Weight loss coverage is the part that changes. Several states added it recently and several dropped it, so check your own plan before you count on it.
What states do not get to decide
States choose whether to cover GLP-1s for weight loss. They do not get a choice about these, where federal rules require coverage of the approved medicine:
- Type 2 diabetes. Long standing. This is the most common route to a covered GLP-1 on Medicaid.
- Lowering the risk of heart attack and stroke. Wegovy, for adults with heart disease who also carry excess weight. Required since March 2024.
- Moderate to severe obstructive sleep apnea. Zepbound, for adults with obesity. Required since December 2024.
If you are under 21 and on full Medicaid benefits, Medicaid's Early and Periodic Screening, Diagnostic and Treatment benefit requires your state to cover services that are medically necessary for you. The state decides medical necessity case by case, so a prescription alone does not guarantee coverage, but it is a stronger right than adults have.
Required does not mean automatic. These are still normally subject to prior approval and other limits, so expect paperwork either way.
Why it depends on the state you live in
Federal law lets each state decide this one for itself. Social Security Act section 1927(d)(2) lists categories of drugs a state Medicaid program is allowed to leave out, and "agents when used for anorexia, weight loss, or weight gain" is on that list. States are permitted to exclude them, not required to, which is why coverage looks so different from one state line to the next.
If weight loss is not covered, another route may be
A denial for weight loss is not always the end of it. These are the same medicines, approved by the FDA for other conditions, and a state that excludes weight-loss treatment still has to cover them when you are being treated for one of these. Here is what each approval actually covers:
- Wegovy (semaglutide), for lowering the risk of heart attack and stroke. For adults with known heart disease who also carry excess weight. The FDA approved this use on March 8, 2024, based on the SELECT trial of 17,604 patients. (Novo Nordisk FDA approval announcement)
- Zepbound (tirzepatide), for moderate to severe obstructive sleep apnea. For adults with obesity and moderate-to-severe OSA. Approved by the FDA in December 2024, the first medicine ever approved for sleep apnea. (Eli Lilly FDA approval announcement)
- Ozempic, Mounjaro and similar, for type 2 diabetes. The most widely covered route by far, and states do not get to opt out of it. Federal rules require Medicaid to cover a GLP-1 approved for treating diabetes, though you will usually need prior approval first. (KFF)
You cannot pick an indication to suit the paperwork. This only applies if you actually have the condition and your clinician documents it.
Sources: KFF, coverage counts as of January 2026; Milliman, state changes as of March 2026; Social Security Act section 1927(d)(2). This is general information, not medical or insurance advice.
Cite this page
GlobalGLP1.com. “Does Medicaid cover GLP-1s for weight loss?” Accessed January 2026. https://globalglp1.com/insurance/medicaid
Free to quote with credit and a link back. If you need the underlying figures, our cost report and price transparency index publish downloadable data under CC-BY 4.0.
If Medicaid denies your prior authorization
You can appeal, and the denial notice has to tell you why it was refused.
Medicaid appeals do not work like private insurance appeals. The deadlines are different and it ends at a state hearing rather than an outside review company.
How fast an answer has to come
- Within 24 hours. If your state Medicaid program requires approval before a drug is dispensed, federal law says the system has to respond within 24 hours of the request. That is by phone or another direct method, not a letter in the mail.
- At least a 72-hour supply in an emergency. In an emergency, the pharmacy has to be able to dispense at least a 72-hour supply while the approval is sorted out. This is worth asking for by name at the counter. It does not apply to drugs on a state excluded list.
What the denial notice owes you
- The notice has to say what was decided and why.
- You can demand their criteria. You can ask for copies of everything they relied on, free of charge. That includes the medical necessity criteria they measured you against and the standards behind any coverage limit. Ask for it, then answer it point by point.
- The notice also has to tell you how to appeal, how to ask for a faster decision, and how to ask for treatment to continue while you appeal.
If you are in a Medicaid health plan (managed care)
Most people on Medicaid are in one of these plans. Check your Medicaid card: if it has a health plan's name on it, this is you.
- Appeal to the plan within 60 calendar days. You have 60 calendar days from the date on the denial notice to appeal to your health plan. You can do it by phone or in writing. There is only one level of appeal at the plan. After that it goes to the state.
- The plan answers in 30 calendar days, or 72 hours if it is urgent. It can add up to 14 calendar days. The plan can take up to 14 extra calendar days, either because you asked or because it can show the state it needs more information and the delay helps you. If it was not your idea, the plan has to tell you in writing within 2 calendar days and you can complain about it.
- If the plan still says no, ask the state for a fair hearing. Once the plan upholds the denial, you get somewhere between 90 and 120 calendar days to ask for a State fair hearing. Your state sets the exact number inside that range, so check the notice the plan sends you.
If the plan blows its own deadline: If the plan misses its own deadline, you are treated as having finished the plan appeal and can go straight to a State fair hearing. You do not have to keep waiting.
Some states also offer a free independent medical review before the hearing. It is optional, it has to be free, and it is not allowed to delay anything else. Not every state offers it.
If you are on regular Medicaid (fee for service)
- Ask for a fair hearing, up to 90 days from the date on the notice. There is no plan appeal to do first. You ask the state for a fair hearing directly. States have to give you a reasonable amount of time, and no more than 90 days from the date the notice was mailed.
- A decision normally comes within 90 days. That clock runs from the day the state receives your hearing request.
- Urgent cases: 3 working days. Urgent cases move much faster once the file reaches the state.
Keeping treatment going while you appeal
This only helps if you were already approved for something and the plan is now stopping, reducing or suspending it.
It does not apply to a first request that was turned down. If you have never been approved for the medicine, there is nothing to keep going while you appeal.
- Ask within 10 calendar days. Ask for it within 10 calendar days of the plan sending the notice, or by the date the change was due to take effect, whichever is later.
- If you lose the appeal, the state may be able to bill you for what it covered while you were appealing. Worth knowing before you ask.
- Your doctor can file the appeal for you with your written consent, but they cannot ask for benefits to continue. That request has to come from you.
What helps
- The denial notice itself, plus the criteria you asked them for. That is what you answer.
- A letter from your prescriber covering your BMI, your weight history, other conditions, and why this medicine rather than another.
- What you have already tried, including diet and exercise and any earlier medicines.
- Dates and names from every phone call.
Your prescriber does most of the paperwork. If you do not have one, find a GLP-1 clinic.
Sources: Social Security Act section 1927(d)(5) (drug prior authorization), checked August 3, 2026; eCFR, 42 CFR part 438 subpart F (Medicaid managed care grievances and appeals), Title 42 current as of July 31, 2026; eCFR, 42 CFR part 431 subpart E (fair hearings), Title 42 current as of July 31, 2026; eCFR, 42 CFR 438.404 (what a denial notice must contain), Title 42 current as of July 31, 2026. These are the federal Medicaid rules. Private insurance, Medicare and TRICARE each use a different process with different deadlines. Your state sets the exact figure where a range is shown above, and the notice you were sent is the thing to go by. This is general information, not medical, legal or insurance advice.
Medication Coverage
| Medication | Status | Tier | Notes |
|---|---|---|---|
| Ozempic (semaglutide) | Covered | TierPreferred Drug List (most states) | NotesYour state has to cover a GLP-1 for type 2 diabetes, but it picks which one through its preferred drug list. Ozempic is on most of them. Pre-approval usually required. |
| Wegovy (semaglutide) | Varies | TierVaries by state | NotesFDA-approved for weight management. Some states cover it for weight loss, others don't cover weight loss medications at all, and several states have changed that decision recently in both directions. States must cover it for lowering heart attack and stroke risk in adults with heart disease. |
| Mounjaro (tirzepatide) | Covered | TierPreferred Drug List (most states) | NotesCovered for type 2 diabetes in most states. Some states prefer Mounjaro over Ozempic. |
| Zepbound (tirzepatide) | Varies | TierVaries by state | NotesFDA-approved for weight management. Limited state Medicaid coverage for weight loss. States must cover it for moderate to severe obstructive sleep apnea in adults with obesity. |
| Saxenda (liraglutide) | Varies | TierNon-preferred (most states) | NotesLimited coverage. Many states have restricted or removed Saxenda from their drug lists. |
| Compounded semaglutide | Not Covered | TierN/A | NotesNot covered by any state Medicaid program. |
Prior Authorization
Prior-approval requirements depend on the state, plan, medicine and indication, and not every use requires it. California, for example, covers Wegovy for noncirrhotic MASH without an approved prior authorization, as long as the claim carries the right diagnosis code. Where pre-approval is required, what the state asks for varies, but typically includes a diagnosis code, BMI documentation, and evidence of previous treatment attempts. If your state Medicaid program requires approval before a drug is dispensed, federal law says it has to respond within 24 hours of the request. A response is not the same as an approval.
Cost Estimates
Savings tip: Medicaid copays are capped by federal law, typically $0 to $8 per prescription depending on your state and income level. If you qualify for Medicaid, GLP-1 medications will cost you very little out of pocket.
Requirements for Coverage
- Active Medicaid enrollment in your state
- Meet your state's Medicaid eligibility requirements
- Pre-approval from your state Medicaid program or your Medicaid health plan
- Type 2 diabetes or obesity diagnosis (coverage varies by state for weight management)
- Some states require using a Medicaid-preferred pharmacy
Tips for Getting Approved
Contact your state Medicaid office or your Medicaid health plan to check which drugs are covered
Medicaid managed care plans (like Molina, Centene, Amerigroup) may cover different drugs than regular Medicaid in your state
Patient assistance programs from Novo Nordisk and Eli Lilly may help fill gaps in Medicaid coverage
Some telehealth GLP-1 prescribers accept Medicaid. Check our directory for Medicaid-accepting clinics
Common Denial Reasons & How to Avoid Them
How to avoid: Check your state's Medicaid preferred drug list (PDL). If your GLP-1 isn't on it, ask your doctor to request approval for a non-preferred drug or switch to the one your state does cover.
How to avoid: Whether your state covers GLP-1s for weight loss is its own decision, and several states have changed theirs recently in both directions. See the coverage section on this page for what we can source, then check with your state Medicaid office. Coverage for type 2 diabetes is a separate matter and is required.
How to avoid: Medicaid pre-approval needs thorough paperwork. Include all diagnoses, BMI history, related health conditions, and what treatments haven't worked. Your clinic's billing department can help pull this together.
How to avoid: Your prescribing provider has to be enrolled as a Medicaid provider. Check this before your appointment to avoid coverage problems.
Step Therapy Requirements
Most states require: metformin first, then a sulfonylurea or another diabetes medication (like Jardiance or Farxiga). GLP-1 approval usually requires blood sugar (A1C) above 8% (stricter than commercial insurance) despite being on two oral medications.
Frequently Asked Questions
It depends what you are being treated for. Federal rules require every state Medicaid program to cover a GLP-1 approved for type 2 diabetes, for lowering heart attack and stroke risk, or for moderate to severe sleep apnea, so those are not state choices. Prior authorization may still apply. Weight loss is the part each state decides for itself, and only 13 states covered it under fee-for-service as of January 2026, so that is where coverage varies dramatically. Medicaid copays are minimal by law ($0-$8 per prescription). Compounded semaglutide is not covered by any state Medicaid program.
State Medicaid programs typically cover Ozempic (semaglutide) on the Preferred Drug List for type 2 diabetes, Mounjaro (tirzepatide) on most state PDLs for diabetes (sometimes preferred over Ozempic), Wegovy (semaglutide) with partial state-by-state coverage for weight management, Zepbound (tirzepatide) with limited Medicaid coverage for weight loss, and Saxenda (liraglutide) on Non-Preferred status in most states. Compounded semaglutide is not covered anywhere. The coverage section on this page lists the state decisions we can source.
Usually, if you are being treated for type 2 diabetes. Your state has to cover a GLP-1 for diabetes, but it chooses which one through its preferred drug list, so it could be Ozempic, Mounjaro or another. Ozempic is on most state lists. Pre-approval may be required. Contact your state Medicaid office or your Medicaid health plan to confirm which one is covered and check for any restrictions.
Coverage for weight management varies by state and has been changing in both directions. KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. California, New Hampshire, Pennsylvania and South Carolina ended that coverage around the turn of the year, and North Carolina ended it and then restored it. Since then, MassHealth stopped covering Wegovy, Zepbound, Saxenda and other listed weight-loss medicines prescribed only for weight loss on July 3, 2026, and since October 1, 2026, Rhode Island Medicaid no longer covers Foundayo, Saxenda, Wegovy or Zepbound prescribed solely for weight loss; both still review requests for members under 21 for medical necessity. Most enrollees are in managed care, where the plan can differ from the state fee-for-service rule, so contact your state Medicaid program for your own answer.
No. Medicaid eligibility and benefits are set by each state, so you apply again in your new state and its rules apply, including whether it covers GLP-1 medications for weight loss. If you rely on one of these medicines, check the new state's coverage before you move.
Medicaid copays are minimal by law, typically $0 to $8 per prescription. Some states charge zero copays for all prescriptions. Your out-of-pocket cost will be much less than with commercial insurance.
Yes, most Medicaid managed care health plans cover GLP-1 medications for diabetes. Coverage for weight management varies by health plan and state. Each health plan has its own drug list, so check with your specific plan.
Medicaid coverage for FDA-approved weight management medications like Wegovy and Zepbound is very different from state to state. Some states include these medications on their preferred drug lists and others do not. The coverage section on this page lists the states we can source. Contact your state Medicaid office for the most up-to-date information.
In many states, you can switch health plans during open enrollment or within 90 days of first enrolling. Different health plans within the same state may cover different drugs. Contact your state Medicaid office to learn about your plan switching options and compare what each health plan covers.
Some GLP-1 medications are FDA-approved for adolescents aged 12 and older (including Wegovy). For members under 21 on full Medicaid benefits, Medicaid's Early and Periodic Screening, Diagnostic and Treatment benefit requires states to cover services that are medically necessary. The state decides medical necessity case by case, so a prescription alone does not guarantee coverage. Check with your state Medicaid program for how it reviews these requests.
Find GLP-1 clinics near you
Coverage is only part of the answer. Most GLP-1 clinics charge cash rather than billing insurance, so what you actually pay varies a lot. Tell us your state. We’ll review your request before sharing your details with selected clinics, so they can tell you what it costs.
Find Medicaid GLP-1 Clinics by State
Explore More Resources
Find a GLP-1 Clinic That Takes Your Insurance
Search our directory of 3,318 clinics and filter by insurance, medication, and telehealth availability.
Disclaimer: Insurance coverage information is based on publicly available data and may not reflect your specific plan. Coverage, cost, and requirements can change. Always check with your insurer directly before making treatment decisions.